Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 09-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 439,195 | 115,551 | 138,807 | N/A | 518,100 |
| Marketable Securities | N/A | N/A | N/A | N/A | 178,800 |
| Receivables | N/A | N/A | 192 | N/A | 252,500 |
| Inventories | N/A | N/A | N/A | N/A | 106,400 |
| Other current assets | 11,255 | 7,055 | 3,081 | 0 | 0 |
| TOTAL | $450,450 | $122,606 | $142,080 | $N/A | $1,107,700 |
| Non-Current Assets | |||||
| PPE Net | 1,629 | 1,376 | 1,540 | N/A | 146,500 |
| Investments And Advances | 47,908 | 0 | 0 | 0 | 0 |
| Intangibles | 10,179 | 8,434 | 6,674 | 0 | 81,900 |
| Other Non-Current Assets | 3,526 | 5,266 | 264 | 0 | 138,400 |
| TOTAL | $63,242 | $15,076 | $8,478 | $N/A | $366,800 |
| Total Assets | $513,692 | $137,682 | $150,558 | $N/A | $1,474,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,631 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 5,279 | 3,329 | 6,750 | 0 | 97,200 |
| Accrued Expenses | N/A | N/A | 13,650 | N/A | 111,100 |
| Other current liabilities | 30,375 | 15,430 | 1,765 | N/A | N/A |
| TOTAL | $40,436 | $19,943 | $22,354 | $N/A | $288,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 650,800 |
| Other Non-Current Liabilities | 137,751 | 6,583 | 1,961 | 0 | 99,300 |
| TOTAL | $137,751 | $6,583 | $1,961 | $N/A | $751,400 |
| Total Liabilities | $178,187 | $26,526 | $24,315 | $N/A | $1,040,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 97,156 |
| Common Shares | 6,314 | 4,361 | 401 | N/A | 23,700 |
| Retained earnings | -694,859 | -448,569 | -332,085 | N/A | -898,400 |
| Other shareholders' equity | 42,994 | 5,442 | 5,659 | 0 | -15,200 |
| TOTAL | $335,505 | $111,156 | $126,243 | $N/A | $434,400 |
| Total Liabilities And Equity | $513,692 | $137,682 | $150,558 | $0 | $1,474,500 |